Detecting and Excluding Coronavirus disease 2019 (COVID-19) at the Point of Need (360G-Wellcome-220764_Z_20_Z)
Rapid diagnostics have been identified by the WHO R & D Blueprint as a critical unmet need for the control of COVID-19 - particularly in the absence of a vaccine and proven antiviral agents. Our primary objective is to develop a low cost, high performance rapid test for the detection and exclusion of SARS-CoV-2, the causative virus of coronavirus disease 2019 (COVID-19). The technology will be made available in line with the Global Access Policy for Gavi-eligible countries that are most vulnerable to onward transmission of COVID-19 and of limited detection due to insufficient laboratory capacity. The RDT will be appropriate for assembly and manufacture with multiple quality-assured partners to meet demand.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded |
0
|
| Applicant Surname | Adams |
| Approval Committee | Epidemic Technical Advisory Panel |
| Award Date | 2020-09-30T00:00:00+00:00 |
| Financial Year | 2019/20 |
| Grant Programme: Title | Coronavirus |
| Internal ID | 220764/Z/20/Z |
| Lead Applicant | Dr Emily Adams |
| Other Applicant(s) | Dr Amadou Sall, Dr Joe Fitchett, Prof Luis Cuevas, Prof Sanjeev Krishna |
| Partnership Name | Wellcome-DFID Epidemic Preparedness |
| Partnership Value | 888104 |
| Planned Dates: End Date | 2022-09-04T00:00:00+00:00 |
| Planned Dates: Start Date | 2020-03-05T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | East of England |